David Brown

1.8k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

David Brown is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, David Brown has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 13 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in David Brown's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Tuberculosis Research and Epidemiology (6 papers). David Brown is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Tuberculosis Research and Epidemiology (6 papers). David Brown collaborates with scholars based in United States, Sweden and United Kingdom. David Brown's co-authors include R.W. II Potter, Michael A. Clynne, George L. Drusano, Arnold Louie, Steven Fikes, Michael Neely, Weiguo Liu, Brian VanScoy, Robert Kulawy and T. E. Weier and has published in prestigious journals such as PLoS ONE, Journal of Applied Physics and Nature Reviews Drug Discovery.

In The Last Decade

David Brown

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Freezing point depression of aqueous sodium chloride solutions

1978 479 citations R.W. II Potter, Michael A. Clynne et al. Economic Geology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Brown United States	17	396	329	292	264	247	40	1.4k
April N. Abbott United States	20	141 0.4×	132 0.4×	120 0.4×	58 0.2×	39 0.2×	40	1.3k
G. B. Patel Canada	41	187 0.5×	213 0.6×	2.1k 7.3×	54 0.2×	15 0.1×	124	4.7k
Sumati Bhatia Germany	22	437 1.1×	39 0.1×	543 1.9×	117 0.4×	71 0.3×	61	1.8k
Ning Gao United States	28	52 0.1×	763 2.3×	770 2.6×	481 1.8×	27 0.1×	103	2.7k
Tetsuo Matsuda Japan	22	515 1.3×	11 0.0×	315 1.1×	108 0.4×	96 0.4×	73	1.9k
Miki Takahashi Japan	28	596 1.5×	16 0.0×	580 2.0×	95 0.4×	34 0.1×	157	3.0k
Bin Xia China	16	140 0.4×	96 0.3×	257 0.9×	31 0.1×	24 0.1×	43	658
Richard D. Harvey United Kingdom	21	41 0.1×	44 0.1×	388 1.3×	41 0.2×	21 0.1×	96	1.5k
Uwe Petersen Germany	11	88 0.2×	94 0.3×	86 0.3×	223 0.8×	69 0.3×	46	537

Countries citing papers authored by David Brown

Since Specialization

Citations

This map shows the geographic impact of David Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brown more than expected).

Fields of papers citing papers by David Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brown. The network helps show where David Brown may publish in the future.

Co-authorship network of co-authors of David Brown

This figure shows the co-authorship network connecting the top 25 collaborators of David Brown. A scholar is included among the top collaborators of David Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Brown. David Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2023). Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model. Frontiers in Pharmacology. 14. 1291885–1291885. 6 indexed citations

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2022). Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology. 13. 874176–874176. 22 indexed citations

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2022). Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections. Frontiers in Pharmacology. 13. 1035841–1035841. 21 indexed citations

Johnson, Jesse A., et al.. (2021). Pulsed laser melting of implant amorphized Si1-xGex thin films. Applied Surface Science. 564. 150408–150408. 2 indexed citations

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2021). Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology. 12. 682135–682135. 28 indexed citations

Louie, Arnold, Michael S. Maynard, David Brown, et al.. (2018). Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(12). 14 indexed citations

Drusano, George L., Michael Neely, Walter M. Yamada, et al.. (2018). The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(12). 38 indexed citations

Brown, David. (2015). Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?. Nature Reviews Drug Discovery. 14(12). 821–832. 293 indexed citations

Brown, Ashley N., George L. Drusano, Jonathan Adams, et al.. (2015). Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy. mBio. 6(6). e01741–15. 52 indexed citations

10.

Louie, Arnold, Weiguo Liu, Michael Neely, et al.. (2014). Combination Treatment With Meropenem Plus Levofloxacin Is Synergistic Against Pseudomonas aeruginosa Infection in a Murine Model of Pneumonia. The Journal of Infectious Diseases. 211(8). 1326–1333. 32 indexed citations

11.

Drusano, George L., Michael Neely, Michael Van Guilder, et al.. (2014). Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis. PLoS ONE. 9(7). e101311–e101311. 51 indexed citations

12.

Louie, Arnold, Brian VanScoy, Henry S. Heine, et al.. (2011). Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in an In Vitro Pharmacodynamic System. Antimicrobial Agents and Chemotherapy. 56(1). 513–517. 16 indexed citations

13.

Meyers, Marvin J., et al.. (2009). Synthesis oftert-Butyl 6-Oxo-2-azaspiro[3.3]heptane-2-carboxylate. Organic Letters. 11(16). 3523–3525. 23 indexed citations

14.

Louie, Arnold, Henry S. Heine, Kiho Kim, et al.. (2008). Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 52(7). 2486–2496. 29 indexed citations

15.

Drusano, George L., Ólanrewaju O. Okusanya, David Brown, et al.. (2008). Is 60 Days of Ciprofloxacin Administration Necessary for Postexposure Prophylaxis for Bacillus anthracis ?. Antimicrobial Agents and Chemotherapy. 52(11). 3973–3979. 10 indexed citations

16.

Breuil, Colette, et al.. (1995). Immunolocalization of a proteinase of the sap-staining fungus Ophiostoma piceae using antibodies to proteinase K. Canadian Journal of Botany. 73(10). 1604–1610. 4 indexed citations

17.

Potter, R.W. II, Michael A. Clynne, & David Brown. (1978). Freezing point depression of aqueous sodium chloride solutions. Economic Geology. 73(2). 284–285. 479 indexed citations breakdown →

18.

Barkai, A., et al.. (1978). Application of an improved cerebroventricular perfusion technique in the rabbit: Effects of pentobarbital or haloperidol on monoamine metabolites and proteins in the perfusate. Neuropharmacology. 17(6). 409–414. 7 indexed citations

19.

Potter, R.W. II, et al.. (1977). New method for determining the solubility of salts in aqueous solutions at elevated temperatures. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 46 indexed citations

20.

Brown, David, et al.. (1966). Fluoro-complexes of quinquevalent protactinium. Journal of the Chemical Society A Inorganic Physical Theoretical. 254–254. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact